Research funder · United States

Michael J. Fox Foundation for Parkinson's Research

Non-profit organization in the USA

michaeljfox.org

Grants since 2016: 1 275
Awarded, last 5 years (where amounts are published): —
Funded works, last 5 years: 3 085
Funded works, all time: 6 716

Grants

2024 · research · Parkinson’s Disease Therapeutics Pipeline Program

IND-enabling Studies of a Molecule that Enhances Mitophagy as Disease-modifying Therapy for Parkinson's Disease

Bahareh (Spring) Behrouz · Vincere Biosciences Inc

2024 · research · Parkinson’s Disease Therapeutics Pipeline Program

Assessing the Safety and Efficacy of a Novel Enzyme Inhibitor in Reducing Neuroinflammation and Enhancing Neuroprotection in Parkinson’s Disease

Cindy Mcreynolds · Eicosis

2024 · research · [RFA] Use of PD Biosamples - Spring 2020

Neurotoxic Inflammatory Metabolites as Biomarkers of Disease Progression in Parkinson’s Disease

Lena Brundin · Center For Neurodegenerative Science; Van Andel Research Institute

2024 · research · Therapeutic Pipeline Program

Photoreceptor-directed Light Therapy in Parkinson’s Disease

Beatrix Feigl · Queensland University of Technology

2024 · research · Accelerating Biological Understanding and Therapeutic Translation for PD-Biology

Enhancing Removal of Damaged Mitochondria in Neurons by Inhibiting the Enzyme Usp8

Elena Ziviani · University of Padua

2024 · research · Research Grant

(SUPPLEMENT) Cataloguing Proteomic Differences in LRRK2-Associated Parkinsonism With and Without Evidence of Pathologic Neuronal Alpha-synuclein

Lana Chahine · University of Pittsburgh

2024 · research · ASAP CRN Competitive Renewal Opportunity

Determining the Role of Proteins Associated with Parkinson’s Disease in T cell-Mediated Destruction of Dopamine Neurons

Michel Desjardins · Université de Montréal

2024 · research · Parkinson’s Disease Therapeutics Pipeline Program

Development of Novel LRRK2 Inhibitors for the Treatment of Parkinson’s Disease

H. Rachel Lagiakos · Schrodinger (United States)

2024 · research · Research Grant

Planning for a Dynamic Microsimulation Model of the Health and Financial Effects of Parkinson’s Disease

Julie Zissimopoulos · University of Southern California

2024 · research · Spring 2022 RFA: Therapeutic Pipeline Program Pre-Clinical

(SUPPLEMENT) Targeting Phosphoinositides for Parkinson’s Disease Therapy

Ronit Sharon · Hebrew University of Jerusalem

2023 · research · Research Resources Imaging Program

Development of Biomarkers Based on Brainstem Nuclei for Prodromal Parkinson's Disease

Marta Bianciardi · Harvard University

2023 · research · Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program

Development and Assessment of LRRK2 Type II Inhibitors as Potential Therapeutics for Parkinson’s Disease

Dario Alessi · MRC Protein Phosphorylation and Ubiquitylation Unit

2023 · research · Circuits & Cellular Targets for PD’s Symptoms

Unbiased Identification of New Targets for Deep Brain Stimulation to Treat Gait and Balance Impairments in Parkinson’s Disease

Gregoire Courtine · Faculty Of Life Science At Ecole Polytechnique Fédérale De Lausanne (epfl)

2023 · research · Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program

Targeting the Blood-brain Immune Axis to Prevent Progression of Parkinson’s Disease

2023 · research · Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program

Effect of SAR-CoV-2 on Experimental Parkinsonism in a Preclinical Model of Parkinson’s Disease

Richard Jay Smeyne · Thomas Jefferson University

2023 · research · Accelerating the Translation of Parkinson's Disease Therapies

Evaluating Polyamines as Biomarkers for Parkinson’s Disease

Peter Vangheluwe · KU Leuven

2023 · research · Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program

(Supplement) Cellular Brain Repair for Parkinson’s Disease: Preclinical Therapeutic Validation of Biomaterial-supported Cell Transplants Coupled with Immunosuppression

Eilís Dowd · Ollscoil na Gaillimhe – University of Galway

2023 · research · Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program

Targeting the Blood-brain Immune Axis to Prevent Progression of Parkinson’s Disease

2023 · research · Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program

Analysis of the Lysosomal Lipid Metabolism Pathway and Other Pathways, Subgroups and Stages in Parkinson’s Disease

Ziv Gan-Or · McGill University

2023 · research · Parkinson’s Disease Therapeutics Pipeline Program

Development of Parkin Activators for the Treatment of Parkinson’s Disease

Tina Schwabe · Nine Square Therapeutics

2023 · research · Research Grant

Ensuring Diversity and Equity in Parkinson’s Disease Research and Care

Katie Brittain · Newcastle University

2023 · research · Research Grant

Validation of Gap Junction Proteins as a New Therapeutic Target for Impeding the Cell-to-cell Spread of Alpha-synuclein in Parkinson’s Disease and Related Synucleinopathies

Martin Hallbeck · Linköping University

2023 · research · Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program

Effects of Chemical Modifications on Aggregation of Alpha-synuclein

Jean-Christophe Rochet · Purdue University West Lafayette

2023 · research · Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program

Implementation and Validation of Lysosome-specific Tests of GCase Activity in Cell Lines and Human Peripheral Blood

Esther Sammler · University of Dundee

2023 · research · Accelerating Early Proof-of-Concept Testing of Promising PD Therapies

(Supplement) Testing the Neuroprotective Efficacy of Modulating the Lysosomal Gene Atp6v0a1

Rita Marie Cowell · University of Alabama at Birmingham

2023 · research · Translational Pipeline Program

Development of a Small Interfering RNA that Reduces Production of Alpha-synuclein in Parkinson's Disease

Ken Yamada · University of Massachusetts Chan Medical School

2023 · research · Research Grant

Exploiting a Novel Mechanism for Gene Regulation to Develop Innovative, Targeted Therapies for Parkinson’s Disease

Roman Urfer · Selonterra, Inc.

2023 · research · Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program

Discovering Ocular Biomarkers of Parkinson’s Disease

Jayashree Kalpathy-Cramer · University of Colorado Anschutz

2023 · research · Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program

Examining the Role of LRRK2 and Glucocerebrosidase Dysfunction in Exosome-mediated Release of the Lipid Biomarker Bis(monocylglycero)phosphate in Parkinson's Disease

Albert Lu · The Biomedicine Department, Faculty Of Medicine And Health Sciences At University Of Barcelona

2023 · research · Parkinson’s Pathway Molecular Data Analysis Program

Assessing the Ability of Dapansutrile, a Selective, Oral Inhibitor of the NLRP3 Neuroinflammatory Pathway, to Mitigate Progression of Parkinson’s Disease

Nadia Stefanova · Universität Innsbruck

2023 · research · Research Grant

(SUPPLEMENT) Development of an Imaging Tracer for Measuring Alpha-synuclein

Helen Mitchell · Merck & Co., Inc.

2023 · research · Translational Pipeline Program

Inhibiting Faulty DNA Repair as a Strategy for Preventing Neuronal Loss in Parkinson’s Disease

Hilde Loge Nilsen · University of Oslo

2023 · research · Biomarkers to Support Therapeutic Trials Program

Using the Chemical Modification of Alpha-synuclein to Define Disease State and Facilitate Patient Stratification in Parkinson’s Disease

Wilma D.J. Van De Berg · Amsterdam Umc, Vrije University Amsterdam

2023 · research · Data-Driven Subtyping and Stratification Program